Staccato Loxapine Thorough QT/QTc Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Thorough QT/QTc Study
Interventions
DRUG

Inhaled loxapine

Inhaled Staccato Loxapine 10 mg single dose

DRUG

Inhaled placebo

Inhaled Staccato placebo single dose

DRUG

Oral moxifloxacin

Oral moxifloxacin 400 mg

DRUG

Oral placebo

Oral placebo similar in appearance to moxifloxacin 400 mg

Trial Locations (1)

47710

Covance Clinical Research Unit Inc., Evansville

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY

NCT00874237 - Staccato Loxapine Thorough QT/QTc Study | Biotech Hunter | Biotech Hunter